My Quote Request
No products added yet
6505-01-360-5744
20 Products
NDC00002-3145-30
NIZATIDINE CAPSULES
NSN, MFG P/N
6505013605744
NSN
6505-01-360-5744
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NIZATIDINE CAPSULES 300MG 30S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 300 MG NIZATIDINE ACTIVE INGREDIENT
THERAPEUTIC EQUIVALENT: TO AXID BY ELI LILLY
Related Searches:
AXID CAPSULES
NIZATIDINE CAPSULES
NSN, MFG P/N
6505013605744
NSN
6505-01-360-5744
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NIZATIDINE CAPSULES 300MG 30S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 300 MG NIZATIDINE ACTIVE INGREDIENT
THERAPEUTIC EQUIVALENT: TO AXID BY ELI LILLY
Related Searches:
F92D549
ELECTROLYTE INJECTION
NSN, MFG P/N
6505013605790
NSN
6505-01-360-5790
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ADMINISTRATION: INTRAVENOUS INFUSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NORMASOL-R
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: CONTAINS THE FOLLOWING AMOUNTS OF ELECTROLYTES PER LITER; SODIUM 140,POTASSIUM 5,MAGNESIUM 3,CHLORIDE 98,ACETATE 27,AND GLUCONATE 23
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00074-7670-09
ELECTROLYTE INJECTION
NSN, MFG P/N
6505013605790
NSN
6505-01-360-5790
NDC00074-7670-09
ELECTROLYTE INJECTION
NSN, MFG P/N
6505013605790
NSN
6505-01-360-5790
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ADMINISTRATION: INTRAVENOUS INFUSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NORMASOL-R
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: CONTAINS THE FOLLOWING AMOUNTS OF ELECTROLYTES PER LITER; SODIUM 140,POTASSIUM 5,MAGNESIUM 3,CHLORIDE 98,ACETATE 27,AND GLUCONATE 23
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NORMASOL-R
ELECTROLYTE INJECTION
NSN, MFG P/N
6505013605790
NSN
6505-01-360-5790
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ADMINISTRATION: INTRAVENOUS INFUSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NORMASOL-R
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: CONTAINS THE FOLLOWING AMOUNTS OF ELECTROLYTES PER LITER; SODIUM 140,POTASSIUM 5,MAGNESIUM 3,CHLORIDE 98,ACETATE 27,AND GLUCONATE 23
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
F92E049
PROPYLTHIOURACIL TABLETS,USP
NSN, MFG P/N
6505013605792
NSN
6505-01-360-5792
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PROPYLTHIOURACIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROPYLTHIOURACIL TABLETS USP 50MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: LEDERLE LABS
Related Searches:
NDC00005-4609-34
PROPYLTHIOURACIL TABLETS,USP
NSN, MFG P/N
6505013605792
NSN
6505-01-360-5792
NDC00005-4609-34
PROPYLTHIOURACIL TABLETS,USP
NSN, MFG P/N
6505013605792
NSN
6505-01-360-5792
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PROPYLTHIOURACIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROPYLTHIOURACIL TABLETS USP 50MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: LEDERLE LABS
Related Searches:
NDC00143-1480-10
PROPYLTHIOURACIL TABLETS,USP
NSN, MFG P/N
6505013605792
NSN
6505-01-360-5792
NDC00143-1480-10
PROPYLTHIOURACIL TABLETS,USP
NSN, MFG P/N
6505013605792
NSN
6505-01-360-5792
MFG
WEST-WARD PHARMACEUTICAL CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PROPYLTHIOURACIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROPYLTHIOURACIL TABLETS USP 50MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: LEDERLE LABS
Related Searches:
A92E059
HYOSCYAMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505013605793
NSN
6505-01-360-5793
A92E059
HYOSCYAMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505013605793
NSN
6505-01-360-5793
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.125 MILLIGRAMS HYOSCYAMINE SULFATE ACTIVE INGREDIENT
CRITICALITY CODE JUSTIFICATION: FEAT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYOSCYAMINE SULFATE TABLETS USP 0.125MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FORMULATED FOR SUBLINGUAL ADMINISTRATION; MAY ALSO BE TAKEN ORALLY
Related Searches:
LEVSIN SL
HYOSCYAMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505013605793
NSN
6505-01-360-5793
LEVSIN SL
HYOSCYAMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505013605793
NSN
6505-01-360-5793
MFG
SCHWARZ PHARMA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.125 MILLIGRAMS HYOSCYAMINE SULFATE ACTIVE INGREDIENT
CRITICALITY CODE JUSTIFICATION: FEAT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYOSCYAMINE SULFATE TABLETS USP 0.125MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FORMULATED FOR SUBLINGUAL ADMINISTRATION; MAY ALSO BE TAKEN ORALLY
Related Searches:
NDC00091-3532-01
HYOSCYAMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505013605793
NSN
6505-01-360-5793
NDC00091-3532-01
HYOSCYAMINE SULFATE TABLETS,USP
NSN, MFG P/N
6505013605793
NSN
6505-01-360-5793
MFG
SCHWARZ PHARMA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.125 MILLIGRAMS HYOSCYAMINE SULFATE ACTIVE INGREDIENT
CRITICALITY CODE JUSTIFICATION: FEAT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYOSCYAMINE SULFATE TABLETS USP 0.125MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FORMULATED FOR SUBLINGUAL ADMINISTRATION; MAY ALSO BE TAKEN ORALLY
Related Searches:
27-0382-5
POTASSIUM CHLORIDE SOLUTION FOR HEMODIALYSIS
NSN, MFG P/N
6505013606405
NSN
6505-01-360-6405
27-0382-5
POTASSIUM CHLORIDE SOLUTION FOR HEMODIALYSIS
NSN, MFG P/N
6505013606405
NSN
6505-01-360-6405
MFG
NATIONAL MEDICAL CARE MEDICAL PRODUCTS DIV INC DBA ERIKA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3312.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ADDITIVE FOR CONCENTRATE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
POT3312
POTASSIUM CHLORIDE SOLUTION FOR HEMODIALYSIS
NSN, MFG P/N
6505013606405
NSN
6505-01-360-6405
POT3312
POTASSIUM CHLORIDE SOLUTION FOR HEMODIALYSIS
NSN, MFG P/N
6505013606405
NSN
6505-01-360-6405
MFG
FFF ENTERPRISES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3312.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ADDITIVE FOR CONCENTRATE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
HUMULIN
INSULIN HUMAN AND INSULIN HUMAN ISOPHANE SUSPENSION
NSN, MFG P/N
6505013608956
NSN
6505-01-360-8956
HUMULIN
INSULIN HUMAN AND INSULIN HUMAN ISOPHANE SUSPENSION
NSN, MFG P/N
6505013608956
NSN
6505-01-360-8956
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 USP UNITS INSULIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN AND INSULIN HUMAN ISOPHANE SUSPENSION 100UN/ML 10ML
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 50% HUMAN INSULIN ISOPHANE SUSPENSION; 50% HUMAN INSULIN INJECTION; RECOMBINANT DNA ORIGIN (E. COLI BACTERIA)
Related Searches:
HUMULIN 50/50
INSULIN HUMAN AND INSULIN HUMAN ISOPHANE SUSPENSION
NSN, MFG P/N
6505013608956
NSN
6505-01-360-8956
HUMULIN 50/50
INSULIN HUMAN AND INSULIN HUMAN ISOPHANE SUSPENSION
NSN, MFG P/N
6505013608956
NSN
6505-01-360-8956
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 USP UNITS INSULIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN AND INSULIN HUMAN ISOPHANE SUSPENSION 100UN/ML 10ML
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 50% HUMAN INSULIN ISOPHANE SUSPENSION; 50% HUMAN INSULIN INJECTION; RECOMBINANT DNA ORIGIN (E. COLI BACTERIA)
Related Searches:
NDC00002-9515-01
INSULIN HUMAN AND INSULIN HUMAN ISOPHANE SUSPENSION
NSN, MFG P/N
6505013608956
NSN
6505-01-360-8956
NDC00002-9515-01
INSULIN HUMAN AND INSULIN HUMAN ISOPHANE SUSPENSION
NSN, MFG P/N
6505013608956
NSN
6505-01-360-8956
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 USP UNITS INSULIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN AND INSULIN HUMAN ISOPHANE SUSPENSION 100UN/ML 10ML
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 50% HUMAN INSULIN ISOPHANE SUSPENSION; 50% HUMAN INSULIN INJECTION; RECOMBINANT DNA ORIGIN (E. COLI BACTERIA)
Related Searches:
NDC00049-4900-66
SERTRALINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013608958
NSN
6505-01-360-8958
NDC00049-4900-66
SERTRALINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013608958
NSN
6505-01-360-8958
MFG
ROERIG DIV PFIZER INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SERTRALINE HYDROCHLORIDE TABLETS 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EQUIVALENT TO 50 MG SERTRALINE
THERAPEUTIC EQUIVALENT: ZOLOFT BY PFIZER
Related Searches:
ZOLOFT
SERTRALINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013608958
NSN
6505-01-360-8958
ZOLOFT
SERTRALINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013608958
NSN
6505-01-360-8958
MFG
PFIZER INC ROERIG DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SERTRALINE HYDROCHLORIDE TABLETS 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EQUIVALENT TO 50 MG SERTRALINE
THERAPEUTIC EQUIVALENT: ZOLOFT BY PFIZER
Related Searches:
ZOLOFT TABLETS
SERTRALINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013608958
NSN
6505-01-360-8958
ZOLOFT TABLETS
SERTRALINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013608958
NSN
6505-01-360-8958
MFG
PFIZER INC ROERIG DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SERTRALINE HYDROCHLORIDE TABLETS 50MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EQUIVALENT TO 50 MG SERTRALINE
THERAPEUTIC EQUIVALENT: ZOLOFT BY PFIZER
Related Searches:
L92-070
SERTRALINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013608959
NSN
6505-01-360-8959
L92-070
SERTRALINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505013608959
NSN
6505-01-360-8959
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SERTRALINE HYDROCHLORIDE TABLETS 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EQUIVALENT TO 100 MG SERTRALINE
